A Randomized, Double-Blind, Placebo-Controlled,Study to Determine the Short-Term (6-Week) and Long-Term (6 Month) Anti-Psychotic and Cognitive Efficacy, Safety and Tolerability of CYP-1020 Compared to Placebo and Risperidone in Patients With Schizophrenia